Antibiotic Susceptibility Testing Market

ID: MRFR/Pharma/25219-HCR

100 Pages

Rahul Gotadki

September 2025

Antibiotic Susceptibility Testing Market Size, Growth Research Report By Sample Type (Blood Culture, Urine Culture, Pus Culture, Sputum Culture, Cerebrospinal Fluid Culture, Other Sample Types), By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Anaerobic Bacteria, Mycobacteria, Fungi, Parasites), By Test Method (Disk Diffusion, Automated Susceptibility Testing Systems, Agar Dilution Method, Microdilution Method, Molecular Susceptibility Testing) - Competitor Industry Analysis and Trends Forecast Till 2032

Antibiotic Susceptibility Testing Market Research Report — Global Forecast till 2032 Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Antibiotic Susceptibility Testing Market Summary

The Global Antibiotic Susceptibility Testing Market is projected to grow from 3.79 USD Billion in 2024 to 8.1 USD Billion by 2035.

Key Market Trends & Highlights

Global Antibiotic Susceptibility Testing Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 7.15% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 8.1 USD Billion, reflecting a substantial increase from the base year.
In 2024, the market is valued at 3.79 USD Billion, indicating a strong foundation for future growth.
Growing adoption of advanced testing technologies due to the rising prevalence of antibiotic-resistant infections is a major market driver.

Antibiotic Susceptibility Testing Market

CAGR

7.15%

Market Size & Forecast

2024 Market Size	3.79 (USD Billion)
2035 Market Size	8.1 (USD Billion)
CAGR (2025-2035)	7.15%

Major Players

bioMérieux, BD (Becton, Dickinson and Company), Merck Millipore, QIAGEN, Alere Technologies, Thermo Fisher Scientific, bioControl System, IUL Diagnostic, Beckman Coulter, Cepheid, Hologic, Sysmex, Roche Diagnostics, Abbott, Copan

Antibiotic Susceptibility Testing Market Trends

The current trends in the antibiotic susceptibility testing market reveal a shift towards automation and advanced technologies. Laboratories are increasingly adopting automated systems to enhance efficiency, minimize human error, and reduce turnaround time. The integration of artificial intelligence (AI) and machine learning (ML) algorithms allows for faster analysis and interpretation of susceptibility results. This automation trend is expected to continue in the coming years.

The increasing prevalence of antibiotic resistance underscores the urgent need for advanced susceptibility testing methods to guide effective treatment strategies.

U.S. Centers for Disease Control and Prevention (CDC)

Antibiotic Susceptibility Testing Market Drivers

Rising Incidence of Antibiotic Resistance

The increasing prevalence of antibiotic resistance globally drives the demand for antibiotic susceptibility testing. As pathogens evolve and develop resistance to commonly used antibiotics, healthcare providers require reliable testing methods to guide effective treatment strategies. The Global Global Antibiotic Susceptibility Testing Market Industry is witnessing a surge in demand as healthcare systems aim to combat resistant infections. For instance, the World Health Organization reports that antibiotic resistance contributes to approximately 700,000 deaths annually, a figure that could rise significantly if not addressed. This alarming trend underscores the necessity for robust testing solutions, propelling market growth.

Market Segment Insights

Antibiotic Susceptibility Testing Market Sample Type Insights

The global antibiotic susceptibility testing market is segmented by sample type into blood culture, urine culture, pus culture, sputum culture, cerebrospinal fluid culture, and other sample types.

Blood Culture: Blood culture is the most common sample type used for antibiotic susceptibility testing, accounting for over 30% of the global market revenue in 2023. The high prevalence of bloodstream infections and the need for rapid identification of causative pathogens drive the demand for blood culture-based susceptibility testing. Technological advancements, such as automated blood culture systems and rapid diagnostic tests, have further contributed to the growth of this segment.

Urine Culture: Urine culture is another widely used sample type, particularly for diagnosing urinary tract infections (UTIs). The increasing incidence of UTIs, especially among the elderly and immunocompromised individuals, has led to a rise in the demand for urine culture-based susceptibility testing. The availability of non-invasive urine collection methods and rapid diagnostic tests has also supported the growth of this segment.

Pus Culture: Pus culture is primarily used to identify and determine the antibiotic susceptibility of bacteria causing skin and soft tissue infections. The growing prevalence of surgical site infections and the emergence of antibiotic-resistant bacteria have contributed to the increasing demand for pus culture-based susceptibility testing. Technological advancements, such as wound swabs and aspiration techniques, have improved the accuracy and efficiency of pus culture testing.

Sputum Culture: Sputum culture is used to diagnose and determine the antibiotic susceptibility of respiratory tract infections, such as pneumonia and bronchitis. The high prevalence of respiratory infections and the need for targeted antibiotic therapy drive the demand for sputum culture-based susceptibility testing. The development of non-invasive sputum collection methods and rapid diagnostic tests has further supported the growth of this segment.

Antibiotic Susceptibility Testing Market Pathogen Type Insights

The pathogen type segment plays a critical role in the global antibiotic susceptibility testing market segmentation. Among the key pathogen types, gram-positive bacteria held the largest market share of around 38% in 2023 and is projected to maintain its dominance throughout the forecast period.

The widespread prevalence of gram-positive bacterial infections, such as those caused by Staphylococcus aureus and streptococcus pneumoniae, drives the demand for effective antibiotic susceptibility testing solutions. Gram-negative bacteria also represent a significant market segment, accounting for approximately 32% of the global revenue in 2023.

The emergence of multidrug-resistant gram-negative bacteria, such as Pseudomonas aeruginosa and Acinetobacter baumannii, has heightened the need for accurate and rapid susceptibility testing to guide appropriate antibiotic selection.

Anaerobic bacteria, mycobacteria, fungi, and parasites collectively contribute to the remaining market share, with each segment exhibiting unique growth dynamics based on the prevalence of specific infections and the availability of effective diagnostic solutions.

Antibiotic Susceptibility Testing Market Test Method Insights

The global antibiotic susceptibility testing market segmentation by test method includes disk diffusion, automated susceptibility testing systems, agar dilution method, microdilution method, and molecular susceptibility testing.

Disk diffusion held the largest market share in 2023, owing to its simplicity, cost-effectiveness, and wide availability. Automated susceptibility testing systems are expected to grow at the highest CAGR during the forecast period, due to their accuracy, efficiency, and ability to handle high sample volumes. In 2023, the global antibiotic susceptibility testing market revenue for disk diffusion was valued at 1.2 billion USD, and it is projected to reach 1.6 billion USD by 2032, exhibiting a CAGR of 4.5%.

Automated susceptibility testing systems market was valued at 0.9 billion USD in 2023, and it is anticipated to reach 1.5 billion USD by 2032, with a CAGR of 6.3%. The agar dilution method market was valued at 0.6 billion USD in 2023, and it is expected to reach 0.9 billion USD by 2032, with a CAGR of 4.9%. The microdilution method market was valued at 0.5 billion USD in 2023, and it is projected to reach 0.8 billion USD by 2032, exhibiting a CAGR of 5.6%.

The molecular susceptibility testing market was valued at 0.3 billion USD in 2023, and it is anticipated to reach 0.6 billion USD by 2032, with a CAGR of 8.2%.

The increasing prevalence of antimicrobial resistance, rising demand for rapid and accurate antibiotic susceptibility testing, and technological advancements in diagnostic methods are driving the growth of the global antibiotic susceptibility testing market.

Antibiotic Susceptibility Testing Market End User Insights

The end user segment of the global antibiotic susceptibility testing market is segmented into hospitals, clinical laboratories, diagnostic centers, research centers, and pharmaceutical companies. Hospitals account for the largest share of the market, owing to the high volume of antibiotic susceptibility testing performed in these settings.

Clinical laboratories are also a major end user of antibiotic susceptibility testing services, as they provide testing services to hospitals and other healthcare providers. Diagnostic centers are increasingly offering antibiotic susceptibility testing services, as they seek to expand their service offerings and meet the growing demand for these tests.

Research centers are also using antibiotic susceptibility testing to conduct research on the effectiveness of new antibiotics and to develop new methods for detecting and treating antibiotic-resistant bacteria. Pharmaceutical companies are also using antibiotic susceptibility testing to develop new antibiotics and to assess the effectiveness of their existing antibiotics.

Antibiotic Susceptibility Testing Market Application Insights

The global antibiotic susceptibility testing market segmentation by application can be divided into infectious disease diagnosis, antimicrobial stewardship, research and development, clinical trials, surveillance and infection control.

The infectious disease diagnosis segment held the largest market share in 2023 and is expected to continue dominating the market throughout the forecast period. The growth of this segment can be attributed to the increasing prevalence of infectious diseases, rising demand for accurate and rapid diagnosis, and technological advancements in antibiotic susceptibility testing methods.

The Antimicrobial Stewardship segment is expected to witness significant growth owing to the increasing focus on optimizing antibiotic use and reducing antimicrobial resistance. The Research and Development segment is anticipated to grow steadily due to the ongoing research activities aimed at developing new antibiotics and improving susceptibility testing techniques. The Clinical Trials segment is expected to contribute significantly to the market growth as antibiotic susceptibility testing plays a crucial role in evaluating the efficacy and safety of new drugs.

The surveillance and infection control segment is projected to grow at a moderate pace, driven by the need for continuous monitoring of antibiotic resistance patterns and implementing infection control measures to prevent the spread of infections.

Get more detailed insights about Antibiotic Susceptibility Testing Market Research Report — Global Forecast till 2032

Request Free Sample

Regional Insights

Regionally, North America held the largest market share in 2023 and is expected to maintain its dominance throughout the forecast period. The increasing prevalence of antibiotic resistance, coupled with the rising demand for rapid and accurate antibiotic susceptibility testing, is driving market growth in this region.

Europe is another significant market, with a well-established healthcare infrastructure and a high adoption rate of advanced diagnostic technologies. The Asia-Pacific region is anticipated to witness substantial growth over the coming years, owing to the increasing healthcare expenditure, growing awareness about antibiotic resistance, and the presence of a large patient population. South America and the Middle East and Africa (MEA) are also expected to contribute to the overall market growth, albeit at a slower pace compared to other regions.

Global Antibiotic Susceptibility Testing Market, by Region 2023 & 2032 (USD Billion)

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Key Players and Competitive Insights

Major players in the antibiotic susceptibility testing market are constantly striving to gain a competitive edge by introducing new products and technologies. For instance, in March 2023, bioMérieux launched the VITEK MS PRIME, a new mass spectrometry-based identification system for rapid and accurate identification of microorganisms, including antibiotic-resistant bacteria. This launch is expected to strengthen bioMérieux's position in the market and drive growth for the company.

Leading antibiotic susceptibility testing market players are also focusing on strategic partnerships and acquisitions to expand their product portfolios and geographic reach. In January 2023, Thermo Fisher Scientific acquired Mesa Biotech, a leading provider of antimicrobial susceptibility testing solutions. This acquisition is expected to enhance Thermo Fisher's capabilities in the antibiotic susceptibility testing market and provide customers with a comprehensive range of solutions.

bioMérieux is a global leader in the field of in vitro diagnostics, with a strong focus on the development and manufacturing of antibiotic susceptibility testing solutions. The company's VITEK 2 and VITEK MS systems are widely used in clinical laboratories around the world for the rapid and accurate identification and susceptibility testing of bacteria and fungi. bioMérieux is committed to innovation and has a strong pipeline of new products and technologies in development. The company's strong brand recognition, global presence, and commitment to quality make it a formidable competitor in the Antibiotic Susceptibility Testing Market.

BD (Becton, Dickinson and Company) is another major player in the Antibiotic Susceptibility Testing Market. The company offers a comprehensive range of solutions for antibiotic susceptibility testing, including the BD Phoenix and BD Phoenix M50 systems. BD is known for its high-quality products and strong customer support. The company has a global presence and is well-positioned to meet the needs of customers in both developed and emerging markets. BD's focus on innovation and commitment to providing comprehensive solutions make it a strong competitor in the Antibiotic Susceptibility Testing Market.

Key Companies in the Antibiotic Susceptibility Testing Market market include

Industry Developments

Q1 2025: Sysmex Corporation launches point-of-care testing system in Europe to detect antimicrobial susceptibility in just 30 minutes Sysmex Corporation announced the launch of a new point-of-care system in Europe that can detect antimicrobial susceptibility using urine samples from patients suspected of urinary tract infections, delivering results in as little as 30 minutes through proprietary microfluidic technology.

Future Outlook

Antibiotic Susceptibility Testing Market Future Outlook

The Global Antibiotic Susceptibility Testing Market is projected to grow at a 7.15% CAGR from 2024 to 2035, driven by rising antibiotic resistance and technological advancements in testing methodologies.

New opportunities lie in:

Develop rapid testing kits for point-of-care settings to enhance accessibility.
Invest in AI-driven analytics for predictive susceptibility testing to improve treatment outcomes.
Expand partnerships with healthcare providers to integrate testing solutions into routine diagnostics.

By 2035, the market is expected to achieve substantial growth, reflecting increased demand for effective antibiotic stewardship.

Market Segmentation

Antibiotic Susceptibility Testing Market End User Outlook

Hospitals
Clinical Laboratories
Diagnostic Centers
Research Centers
Pharmaceutical Companies

Antibiotic Susceptibility Testing Market Regional Outlook

North America
Europe
South America
Asia Pacific
Middle East and Africa

Antibiotic Susceptibility Testing Market Application Outlook

Infectious Disease Diagnosis
Antimicrobial Stewardship
Research and Development
Clinical Trials
Surveillance and Infection Control

Antibiotic Susceptibility Testing Market Sample Type Outlook

Blood Culture
Urine Culture
Pus Culture
Sputum Culture
Cerebrospinal Fluid Culture
Other Sample Types

Antibiotic Susceptibility Testing Market Test Method Outlook

Disk Diffusion
Automated Susceptibility Testing Systems
Agar Dilution Method
Microdilution Method
Molecular Susceptibility Testing

Antibiotic Susceptibility Testing Market Pathogen Type Outlook

Gram-Positive Bacteria
Gram-Negative Bacteria
Anaerobic Bacteria
Mycobacteria
Fungi
Parasites

Report Scope

Report Attribute/Metric	Details
Market Size 2023	3.5(USD Billion)
Market Size 2024	3.79(USD Billion)
Market Size 2032	6.7(USD Billion)
Compound Annual Growth Rate (CAGR)	6.53% (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023
Market Forecast Units	USD Billion
Key Companies Profiled	BD, Merck Milliporenpara, QIAGEN, Alere Technologies, Thermo Fisher Scientific, bioControl System, IUL Diagnostic, Beckman Coulter, Cepheid, bioMérieux, Hologic, Sysmex, Roche Diagnostics, Abbott, Copan
Segments Covered	Sample Type, Pathogen Type, Test Method, End User, Application, Region
Key Market Opportunities	Increasing Prevalence of Antibiotic Resistance Rising demand for rapid diagnostic tests Technological Advancements in AST Methods Growing Adoption of Automation in AST Expanding use in Clinical Research and Drug Development
Key Market Dynamics	Growing Prevalence of Infectious Diseases Advancements In Molecular Diagnostics Increasing Demand for Personalized Treatment Government Initiatives and Regulations Technological Advancements
Countries Covered	North America, Europe, APAC, South America, MEA

FAQs

What is the market size of the Global Antibiotic Susceptibility Testing Market?

The global antibiotic susceptibility testing market is valued at USD 3.79 billion in 2024 and is projected to grow at a CAGR of 6.53% to reach USD 6.7 billion by 2032.

What are the major regions contributing to the market growth?

North America and Europe are the major regions contributing to the market growth, followed by Asia-Pacific and the Rest of the World.

What are the key factors driving market growth?

The rising prevalence of infectious diseases, increasing demand for personalized medicine, and technological advancements in diagnostic techniques are the key factors driving the market growth.

What are the major applications of Antibiotic Susceptibility Testing?

The major applications of antibiotic susceptibility testing include clinical diagnostics, research and development, and quality control in pharmaceutical manufacturing.

Who are the key competitors in the market?

The key competitors in the antibiotic susceptibility testing market include BD, bioMérieux, Thermo Fisher Scientific, Beckman Coulter, and Qiagen.

What are the major challenges faced by the market?

The major challenges faced by the market include the high cost of testing, regulatory hurdles, and the emergence of antibiotic-resistant bacteria.

What are the key trends in the market?

The key trends in the market include the adoption of automation, the development of rapid diagnostic tests, and the increasing use of molecular diagnostics.

What are the growth opportunities for the market?

The growth opportunities for the market include the rising demand for personalized medicine, the expansion of healthcare infrastructure in developing countries, and the increasing focus on infection control.

What are the major challenges faced by the market?

The major challenges faced by the market include the high cost of testing, regulatory hurdles, and the emergence of antibiotic-resistant bacteria.

What is the forecast for the Antibiotic Susceptibility Testing market?

The global antibiotic susceptibility testing market is projected to grow from USD 3.79 billion in 2024 to USD 6.7 billion by 2032, at a CAGR of 6.53%.

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027